CUE icon

Cue Biopharma

50 hedge funds and large institutions have $10.5M invested in Cue Biopharma in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

53% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 17

89% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 28

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$24K
Puts
$8K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$13.6K
27
$10.9K
28
$9.84K
29
$7.57K
30
$7.57K
31
$6.81K
32
$5.46K
33
$5K
34
$4.54K
35
$3K
36
$2.27K
37
$1.93K
38
$1.89K
39
$1.06K
40
$685
41
$606
42
$332
43
$288
44
$216
45
$179
46
$163
47
$91
48
$76
49
$44
50
$33